Summary

Market Overview
Global Uterine Manipulation Devices Market reached US$ 270.4 million in 2022 and is expected to reach US$ 425.1 million by 2030, growing with a CAGR of 5.9% during the forecast period 2023-2030.
The primary factors expected to boost the global uterine manipulation devices market include the growing disorders associated with the female reproductive system, rising technological advancements, and growing demand for minimally invasive surgical approaches. Typical disorders associated with the female reproductive system includes cervical cancer, uterine fibroids, endometriosis, polycystic ovary syndrome, and interstitial cytosis, among others.
According to World Health Organization, in February 2022, cervical cancer was the fourth highly typical cancer diagnosed in females globally, with an assesed 604,000 recent patients and over 342,000 deaths in 2020. Approximately 90% of the recent cases and deaths worldwide in 2020 surfaced in low- and middle-income nations. The HPV infection is accountable for an assessed 530 000 cases of cervical cancer and over 264 000 cervical cancer deaths annually.
A mixture of uterine manipulators has been designed to enhance surgical performance during laparoscopic female reproductive system surgical procedures, including the McCartney vaginal tube. The commonly utilized uterine manipulation devices include sponge stick, EEA sizer, ZUMI/HUMI, and K-UMI devices, Advincula Arch, The RUMI II System, ClearView, Advincula Delineator, and V-Care, among others available on the market or under development.
Market Dynamics
Growing Cases of Gynecological Disorders
Typical disorders associated with the female reproductive system include cervical cancer, uterine fibroids, endometriosis, polycystic ovary syndrome, and interstitial cytosis, among others. The growing cases of the abovementioned disorders are expected to drive global market growth during the forecast period. For instance, according to the National Cancer Registry Programme, the cancer of breast and cervix uteri was the highly typical cancer diagnosed in females. Cervical cancer makes up for 6-29% of all cancers among females in India.
Also, according to the WHO, Endometriosis impacts approximately 10% (190 million) of reproductive-age women and girls worldwide. Moreover, PCOS is a significant public health problem and is among the most commonly diagnosed hormonal disorders impacting females of reproductive age. The disorder impacts an assessed 8–13% of females of reproductive age, and around 70% of patients are undiagnosed.
Moreover, according to a cross-sectional study conducted at a hospital affiliated with Nanjing medical university in Nanjing, China between September 2021 and February 2022, with a sample size of 977 women aged 18–52 years. The highly predominant gynecological condition was dysmenorrhea with 45.96% of cases, heeded by polycystic ovary syndrome, PCOS accounting for 19.04% of cases, uterine fibroids with 14.23% of cases, spontaneous abortion with 13.20% of cases, 12.59% cases of trouble conceiving, ovarian dysfunction accounting for 11.16% cases and endometriosis accounting for 4.09% of cases.
Increasing Female Health Initiatives
The increasing initiatives to promote awareness and support female reproduction health also drive the global market growth during the forecast period. For instance, in March 2022, the Endometriosis Foundation of America, Inc., a non-profit organization committed to increasing awareness, boosting education, and supporting endometriosis research hosted several weekends of virtual events to mark Patient Day, including peritoneal endometriosis and pain and more serious debilitating condition and its conclusive therapy. This medium is developed to assist individuals to join with others, understand their condition, and share their self-experiences.
Moreover, the FDA Office of Women's Health partnered with the NIH Office of Research on Women's Health to increase awareness regarding various females of distinct ages, races, ethnic backgrounds, and health necessities partaking in clinical trials. Further, the Prevention and Screening Innovation Project Toward Elimination of Cervical Cancer (PRESCRIP-TEC), a three-year project from February 2021 – January 2024 concentrates its investigation on improving the adoption of cervical cancer diagnoses in resource-poor or hard-to-reach environments of Bangladesh, India, Uganda and Slovakia.
Growing Research Activities
The increasing research activities to increase the saftey of uterine manipulators in distinct uterine sugeries are boosting the global market growth. For instance, in January 2022, the investigation "Ultrasound Imaging of Acquired Myometrial Pseudoaneurysm: The Role of Manipulators as an Unusual Cause during Laparoscopic Surgery" demonstrated approving outcomes for ClearView Uterine Manipulator, 7 cm tip in gynecological surgery, exhibiting that they are secure to be utilized during surgical operations.
Moreover, in June 2023, the Asociación RUVID Researchers from the Biomechanics and Ergonomics research body of the Universitat Jaume I, the Abdomino-Pelvic Oncology Surgery Referral Unit (UR-COAP) of the General University Hospital of Castelló and the Fisabio Foundation have designed an atraumatic uterine manipulator for minimally invasive gynecological procedures. Assessed to avert injury to the initial tumor, lower the harm done by manipulating the uterus and decrease the potential migration of potential carcinogens.
Complications Induced by Inapropriate Use
Despite the benefits offered by uterine manipulators, the use of uterine manipulators is not without hazards. Inappropriate usage or placement of the manipulator can provoke damage to the uterus or encompassing tissues and may direct intricacies like bleeding or infection. There is a chance of uterine perforation in the case if laparoscopic uterine manipulator is not placed accurately or too extensive pressure is applied during manipulation. This can guide to bleeding or damage to adjacent organs.
Also, there is a peril of infection at the site if the laparoscopic uterine manipulator is not sterilized properly prior to use. This can lead to postoperative infection, which may need further treatment. The manipulation of the uterus with the laparoscopic uterine manipulator can induce bleeding, particularly if there are fibroids or other uterine anomalies present. These sorts of intricacies can be averted by the appropriate application manipulator into the uterus underneath immediate pelvic visualization.
Lack of Surgical Specialists
The increasing gap in the demand and supply of Obstetricians and Gynecologists is expected to slow the market growth in the forecast period. For instance, according to the March of Dimes, over 2.2 million U.S. females of childbearing age living in “maternity care deserts,” and around 6.9 million have undersized or no access to gynecological healthcare. Half of the nations in the United States do not have any obstetrics and gynecology (OB/GYN) establsihments.
Moreover, the U.S. Department of Health and Human Services in 2021, estimated that the number of OB-GYNs to drop from 50,850 to 47,490 (7%), however the need is estimated to grow from 50,850 to 52,660 (4%) by 2030. Further, the Association of American Medical Colleges (AAMC) estimated a shortage of around 122,000 medics by 2032, and OB/GYN is no anomaly. The initial 2023 data from the American Association of Medical Colleges discloses that the moderate number of applications per obstetrics and gynecology residence program dropped from 663 in 2022 to 650 in 2023.
Segment Analysis
The global uterine manipulation devices market is segmented based on product type, type, application, end-user and region.
Increasing Number of Hysterectomy Procedures Conducted
Hysterectomy is surgery to extract the uterus/womb, out of the procedures specific to females, hysterectomies are the second most performed surgery in the U.S. (after cesarean sections). NIH, estimations indicate that one out of nine females will experience a hysterectomy in their lifetime and that roughly 600,000 operations are conducted annually in the United States. Moreover, according to NIH, in India, the preponderance of hysterectomy procedures was 3.2%, the highest in Andhra Pradesh (8.9%) and the lower in Assam (0.9%). Rural India had elevated a preponderance than urban India.
Further, one out of three women in the U.S. have had a hysterectomy by age 60. Therefore, the growing female geriatric population will also contribute to the segment growth in the forecast period. For instance, according to the National Statistical Office (NSO)’s Elderly in India 2021 report, India’s geriatric residents (aged 60 and above) were estimated to brush 194 million in 2031 from 138 million in 2021, a 41 percent growth over a decade.
Geographical Penetration
North America Accounted for Approximately 37.1% of the Market Share in 2022 Owing to the Growing Cases of Gynecological Disorders
The growing demand for gynecological surgeries owing to increasing cases of gynecological disorders in this region. For instance, according to the American Cancer Society's 2023, estimations around 13,960 fresh cases of invasive cervical cancer are expected to be diagnosed and, over 4,310 females are expected to die from cervical cancer by the end of 2023. Moreover, according to the US Department of Health and Human Services, Endometriosis is estimated to affect over 11% of American females between 15 and 44. It is extremely typical among females in their 30s and 40s and may cause it more difficult to acquire pregnancy.
Moreover, according to CDC, PCOS is among the highly typical reasons for female infertility, impacting 6% to 12%, accounting for around 5 million US females of reproductive age. Interstitial cystitis (IC) is highly typical, the disorder is estimated to impact 3 million to 8 million women and between 1 million to 4 million men in the United States. Further, the Centers for Disease and Prevention (CDC) reports that roughly 600,000 hysterectomies are conducted in the United States annually.
Similarly, according to Behavioral Risk Factor Surveillance System (BRFSS) or the National Health Interview Survey (NHIS), analysis of growing trends in hysterectomy prevalence by age and directional differences by race and ethnicity were observed with less than 2% of women aged 20–29 years and over 4 in 10 females aged 70–79 years documented undergoing hysterectomy. Furthermore, the increasing initiatives and availability of reimbursement policies in the United States ensures the North America's uterine manipulation devices market growth in the forecast period.
For instance, the Medicare covers a doctor considered medically necessary hysterectomy. Again, the U.S. Preventive Services Task Force (USPSTF) suggests screening for cervical cancer every 3 years with a Pap test in females aged 21 to 29 years, and for women ages 30 to 65 years, a Pap test screening every 3 years with high-risk human papillomavirus (hrHPV) testing every 5 years, or every 5 years with both types of tests. Again, the NCI Cervical Cancer ‘Last Mile’ Initiative, a public-private collaboration getting together federal agencies, industry associates, and professional associations to contribute proof regarding the precision and clinical significance of self-sampling-based HPV testing for cervical cancer screening.
Competitive Landscape
The major global players in the market include CooperSurgical Inc., MEDGYN PRODUCTS, INC., CONMED Corporation, Peters Surgical., Zhejiang Geyi Medical Instrument Co.,Ltd, Laborie, HTKD Medical, Bissinger Medizintechnik, Purple Surgical, Ningbo Xinwell Medical Technology Co., LTD., Utah Medical Products, Inc., and Panpac Medical Corp. among others.
COVID-19 Impact Analysis
According to an article titled, "Gynecological Surgery and COVID-19" published in July 2020, an estimated 28 million procedures were delayed or withdrawn globally because of the pandemic, forcing a hold on the diagnosis and treatment of over 2 million cancer patients. In Brazil, both the National Health Agency (ANS) and National Health Surveillance Agency (ANVISA) advised the postponement of elective and non-essential procedures, caused a significant impact on the number of surgical procedures that decreased by 33.4% in this period.
Moreover, according to a nationwide survey by the Japan Society of Obstetrics and Gynecology, the whole number of surgeries dropped from 129,648 in 2019 to 118,565 in 2020, accounting for 8.5%, for all surgical operations. Nevertheless, there was steep growth in the number of robotic procedures conducted in 2020 corresponded to that in 2019 for all inhabitants. The number of entire hysterectomies declined markedly from 15,385 in 2019 to 12,531 in 2020, a demonstrating a drop of 10.1%.
Again, earlier during the pandemic, ambulatory visitings at some medical centers in the U.S. dropped significantly, with a concurrent growth in telehealth visits. Yet, the transformation of in-person care to telemedicine care was inconsistent across experties. Procedure volumes were even dropped throughout the multiple specialties.
Surprisingly, actually volumes for some sorts of emergency department care were attenuated, including for some gynecologic disorders. COVID-19 has altered clinical and surgical approaches in benign gynecology. It has directed medics to begin employing telemedicine for gynecologic care more readily, and considerable gynecologists have continued to employ this approach of health care even when the pandemic has subsided.
By Product Type
• Tintara Type
• Hohl Type
• Donnez Type
• Advincula Arch Type
• Others
By Type
• Single-Use
• Multi-Use
By Application
• Hysterectomy
o Partial Hysterectomy
o Total Hysterectomy
o Radical Hysterectomy
• Laparoscopic Ovarian Cystectomy
• Myomectomy
• Others
By End-User
• Hospitals
• Gynecological Clinics
• Ambulatory Surgical Canters
• Academic & Research Centers
• Others
By Region
• North America
o U.S.
o Canada
o Mexico
• Europe
o Germany
o UK
o France
o Italy
o Spain
o Rest of Europe
• South America
o Brazil
o Argentina
o Rest of South America
• Asia-Pacific
o China
o India
o Japan
o Australia
o Rest of Asia-Pacific
• Middle East and Africa
Key Developments
• In October 2021, Laborie Medical Technologies Corp. (Laborie), a specialist medical technology corporation, acquired Pe lvalon, Inc., a privately owned medical device corporation established in Redwood City, CA.
• In September 2021, Boston Scientific Corporation, a biomedical/biotechnology engineering firm and multinational manufacturer of medical devices, completed the acquisition of Devoro Medical, a privately held corporation. Devoro Medical specializes in designing minimally invasive devices for abnormal uterine bleeding.
• In February 2021, CooperSurgical Inc., a market leader in the designing, manufacturing, and commercialization of medical devices utilized to advance women's healthcare and minimally invasive surgery completed the acquisition of AEGEA Medical. The acquisition was expected to allow the corporation to expand its women’s healthcare product line.
Why Purchase the Report?
• To visualize the global uterine manipulation devices market segmentation based on product type, type, application, end-users and region as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development.
• Excel data sheet with numerous data points of uterine manipulation devices market-level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as excel consisting of key product of all the major players.
The global uterine manipulation devices market report would provide approximately 61 tables, 58 figures and 186 Pages.
Target Audience 2023
• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies

ページTOPに戻る

Table of Contents